QR kód

RITUXIMAB TREATMENT EFFICACY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS REFRACTORY TO STANDARD THERAPY IN THE LONG-TERM FOLLOW-UP

Objective. To evaluate the efficacy and safety of rituximab (RTM) treatment in the long-term follow-up of patients with systemic lupus erythematosus (SLE) refractory to standard therapy. Material and methods. RTM therapy was prescribed to 97 SLE patients with high disease activity and insufficient e...

Celý popis

Uloženo v:
Hlavní autoři: M. E. Tsanyan, S. K. Soloviev, A. V. Torgashina, E. N. Aleksandrova, S. G. Radenska-Lopovok, E. V. Nikolaeva, E. L. Nasonov
Médium: Artigo
Jazyk:Russo
Vydáno: IMA PRESS LLC 2014-06-01
Edice:Научно-практическая ревматология
Témata:
systemic lupus erythematosus
rituximab
long-term follow-up
b-cells
depletion.
On-line přístup:https://rsp.mediar-press.net/rsp/article/view/1919
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky